SCHEMBL4473228

SCHEMBL4473228

CC(C)C1=Cc2c(cccc2-c2cccc3ccccc23)[CH]1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 1/20 0.37
ALOX5 P09917 1/20 0.37
PPARG P37231 5/20 0.36
PPARA Q07869 5/20 0.36
AKR1C3 P42330 1/20 0.35
AKR1C2 P52895 1/20 0.35
MAPT P10636 2/20 0.35
RAB9A P51151 2/20 0.35
NPC1 O15118 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
POLB P06746 1/20 0.33
CDC25A P30304 1/20 0.33
CDC25B P30305 1/20 0.33
ALDH1A1 P00352 2/20 0.32
CYP2A6 P11509 1/20 0.32
GPR84 Q9NQS5 1/20 0.32
DHFR P00374 1/20 0.32
KDM4E B2RXH2 1/20 0.32
MEN1 O00255 1/20 0.32
GLA P06280 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4478710 0.85 PPARG (0.34) PTPN1ALOX5PPARGPPARAAKR1C3
SCHEMBL4465143 0.83 ALOX5 (0.33) PTPN1ALOX5PPARGPPARAAKR1C3
SCHEMBL4464838 0.80 ALDH1A1 (0.38) MAPTRAB9AALDH1A1CYP2A6KDM4E
SCHEMBL15603402 0.79 CDC25A (0.33) CDC25ACDC25B
SCHEMBL4470390 0.79 GSTP1 (0.41) AKR1C3AKR1C2SMN1; SMN2ALDH1A1DHFR
SCHEMBL4457465 0.79 CDC25B (0.35) PTPN1PPARGPPARACDC25ACDC25B
SCHEMBL714806 0.79 ALDH1A1 (0.39) PTPN1POLBALDH1A1CYP2A6DHFR
SCHEMBL6758599 0.75 PPARG (0.36) PTPN1PPARGPPARAPOLBALDH1A1
SCHEMBL8615597 0.75 ALOX15 (0.37) PTPN1MAPTRAB9ANPC1SMN1; SMN2
SCHEMBL1241787 0.74 CDC25A (0.32) MAPTRAB9ANPC1SMN1; SMN2CDC25A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1548023-B1 Transition metal compound, catalyst system and the use of the latter for the polymerisation and copolymerisation of olefins BASELL POLYOLEFINE GMBH (DE) 2013-08-14 EP disclosed
US-7569651-B2 Transition metal compound, ligand system, catalyst system and its use for the polymerization and copolymerization of olefins BASELL POLYPROPYLEN GMBH (DE) 2009-08-04 US disclosed
US-7342078-B2 Transition metal compound, ligand system, catalyst system and the use of the latter for polymerisation and copolymerisation of olefins BASELL POLYOLEFINE GMBH (DE) 2008-03-11 US disclosed
US-7214745-B2 Process for producing polymer DENKI KAGAKU KOGYO KABUSHIKI KAISHA (JP) 2007-05-08 US disclosed
US-20060020096-A1 Transition metal compound, ligand system, catalyst system and its use for the polymerization and copolymerization of olefins SCHOTTEK JORG 2006-01-26 US disclosed
US-20050176901-A1 Process for producing polymer DENKI KAGAKU KOGYO KABUSHIKI KAISHA (JP) 2005-08-11 US disclosed
EP-1548037-A2 Random propylene-ethylene copolymers Basell Polyolefine GmbH (DE) 2005-06-29 EP disclosed
EP-1548023-A2 Transition metal compound, catalyst system and the use of the latter for the polymerisation and copolymerisation of olefins Basell Polyolefine GmbH (DE) 2005-06-29 EP disclosed
EP-1548022-A2 Transition metal compound, ligand system, catalyst system and the use of the latter for the polymerisation and copolymerisation of olefins Basell Polyolefine GmbH (DE) 2005-06-29 EP disclosed
CN-1191285-C Ethylene/alpha-olefin/unconjugated polyene copolymer rubber, rubber composition for sealing, molded rubber for sealing, and process for producing the molded rubber MITSUI CHEMICALS INC (JP) 2005-03-02 CN disclosed
US-20030149199-A1 Transition metal compound, ligand system, catalyst system and the use of the latter for polymerisation and copolymerisation of olefins BASELL POLYPROPYLEN GMBH (DE) 2003-08-07 US disclosed
CN-1310730-A Ethylene-alpha-olefin-nonconjugated polyene copolymer rubber, rubber composition for sealing, molded rubber article for sealing, and process for producing molded article MITSUI CHEMICALS INC (JP) 2001-08-29 CN disclosed
CN-1065866-C Process for converting achiral meso form of ansa-metallocene complex into chiral racemic form BASF AG (DE) 2001-05-16 CN disclosed
CN-1190398-A Process for converting achiral meso form of ansa-metallocene complex into chiral racemic form BASF AG (DE) 1998-08-12 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030149199-A1 Transition metal compound, ligand system, catalyst system and the use of the latter for polymerisation and copolymerisation of olefins PORCN, PGR, PPOX PTPN1 4043/4885ALOX5 116/4885PPARG 455/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.